The Latest Biobanking Industry Statistics Explained
The global biobanking market size was valued at USD 2.61 billion in 2020.
The statistic stating that the global biobanking market size was valued at USD 2.61 billion in 2020 signifies the total revenue generated by the biobanking industry worldwide during that year. Biobanks are repositories that store biological samples for research purposes, such as tissue, blood, or DNA. The market size of USD 2.61 billion indicates the economic value of the biobanking sector in 2020, highlighting the importance and growth of the industry in supporting various fields like healthcare, genetics, and drug development. This statistic showcases the increasing demand for biological samples for research and the significant role that biobanks play in advancing scientific knowledge and medical innovation.
It is forecasted to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028.
The statistic “It is forecasted to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028” indicates that the subject of analysis, such as a company’s revenue, industry sector, or market segment, is expected to grow consistently over the specified time period. The compound annual growth rate represents the year-over-year growth rate applied to the initial value to show the effective annual growth rate. In this case, with a CAGR of 6.2%, the subject is forecasted to experience a steady increase of 6.2% per year from 2021 to 2028, resulting in significant overall growth by the end of the period. This statistic provides insights to stakeholders, investors, and decision-makers about the expected trajectory and potential opportunities for the subject under consideration.
By 2025, the human biological samples market, which establishes the basis for biobanking, is projected to reach $33.5 billion.
The statistic that by 2025, the human biological samples market is projected to reach $33.5 billion reflects the anticipated significant growth in the biobanking industry. The increasing demand for biological samples for research purposes, such as genetic studies, drug development, and personalized medicine, is driving the growth of this market. Biobanks play a crucial role in collecting, storing, and managing diverse biological samples, including tissues, blood, DNA, and cells, to support various scientific and medical endeavors. This projected market value indicates the growing importance and investment in biobanking infrastructure and services to advance scientific knowledge and improve healthcare outcomes through personalized and precision medicine approaches.
The equipment segment accounted for the largest revenue share of more than 35.0% in 2020.
The statistic indicates that the equipment segment generated the highest proportion of total revenue among all the segments in 2020, representing over 35.0% of the total revenue for that year. This suggests that the equipment category played a significant role in contributing to the overall revenue of the business or industry during the specified period. This information is valuable for stakeholders and decision-makers as it highlights the importance of the equipment segment in driving revenue and may influence strategic planning, resource allocation, and investment decisions within the organization.
The Asia Pacific biobanking market is expected to witness the fastest growth over the forecast period.
This statistic indicates that the Asia Pacific biobanking market is projected to experience the highest rate of expansion compared to other regions over a specified timeframe. This growth is likely driven by various factors such as increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, advancements in biobanking technologies, and the growing emphasis on personalized medicine. The region’s large population base, particularly in countries like China and India, provides a significant market opportunity for biobanking services and products. Additionally, the increasing focus on research and development activities across various sectors in the Asia Pacific region is expected to contribute to the growth of the biobanking market.
The population-based biobanks segment held the largest market share of over 30.0% in 2020.
This statistic suggests that in 2020, the population-based biobanks segment dominated the market by holding over 30.0% of the total market share. Population-based biobanks refer to repositories of biological samples collected from a specific population or community for research purposes. The fact that this segment held the largest market share indicates its significant importance and widespread adoption within the biobanking industry. This could be due to the potential benefits of studying large, diverse population samples for understanding various health conditions, genetic factors, and personalized medicine. This statistic highlights the growing interest and investment in population-based biobanks for advancing healthcare research and innovation.
North America dominated the biobanking market with the largest revenue share of over 40% in 2020.
This statistic indicates that North America held a significant position in the biobanking market in 2020 by generating more than 40% of the total revenue in this industry. This dominance suggests that North America had a strong influence and presence in the biobanking sector compared to other regions globally. Factors contributing to this dominance may include advanced healthcare infrastructure, technological capabilities, high investment in research and development, and a large number of biobanks in the region. The statistic highlights North America as a key player in the biobanking market, positioning the region as a leader in the collection, storage, and distribution of biological samples for research and clinical purposes.
Biobanks in Australia hold more than 40 million samples.
The statistic that “Biobanks in Australia hold more than 40 million samples” indicates that there are extensive collections of biological samples stored in biobanks throughout Australia. These samples encompass a range of biological materials, such as blood, tissue, and DNA, collected from individuals for research purposes. Biobanks play a crucial role in scientific and medical research by providing researchers with access to a large number of samples that can be used to study various health conditions, genetic factors, and environmental influences. The significant number of samples held in Australian biobanks highlights the country’s commitment to advancing research and advancing healthcare through the use of comprehensive biobanking resources.
The University of Alaska biobank includes over 25,000 samples.
The statistic ‘The University of Alaska biobank includes over 25,000 samples’ indicates that the biobank at the University of Alaska holds a substantial collection of biological samples for research purposes. These samples could include various types of biological materials such as blood, tissue, or DNA samples gathered from a diverse range of individuals. The large number of samples suggests that the biobank is well-established and likely contains a wealth of valuable data for researchers studying various health conditions, genetic factors, or other scientific inquiries. This extensive collection of samples can serve as a valuable resource for advancing research and understanding in various fields of study.
According to Biobank Sweden, there are presently about 900 biobanks in Sweden.
The statistic reveals that there are approximately 900 biobanks in Sweden, as reported by Biobank Sweden. Biobanks play a crucial role in scientific and medical research by storing biological samples, such as blood, tissue, and DNA, for future analysis. The presence of such a significant number of biobanks highlights the country’s commitment to advancing research and improving healthcare outcomes through the collection and utilization of biological materials. This vast network of biobanks provides researchers with access to a diverse range of samples, facilitating various studies on genetics, disease mechanisms, and personalized medicine. The statistic emphasizes the importance of biobanks as valuable resources in the scientific community and reinforces Sweden’s leadership in biomedical research and innovation.
It is estimated that 100 million samples in biobanks in Korea.
The statistic “It is estimated that 100 million samples in biobanks in Korea” suggests that there are approximately 100 million biological samples stored in biobanks across South Korea. Biobanks are facilities that store biological samples such as DNA, tissues, and blood for research purposes. This statistic indicates a significant investment in collecting and preserving biological material for use in various scientific studies and medical research. The large number of samples reflects the importance and potential of biobanks in advancing medical research, personalized medicine, and understanding of human health and diseases in the Korean population.
By 2026, the predicted value of the market for bio-preservation systems should exceed $5.5 billion.
The statistic “By 2026, the predicted value of the market for bio-preservation systems should exceed $5.5 billion” indicates that industry experts and analysts project substantial growth in the market value of bio-preservation systems over the next few years. This forecast suggests that the demand for bio-preservation systems, which are used to store biological samples and materials for research, medical, or industrial purposes, is expected to increase significantly by 2026. The estimated value of over $5.5 billion demonstrates the potential for expansion and investment in this sector, driven by factors like technological advancements, increasing research and development activities, and the growing importance of preserving biological materials for various applications.
The global biobanking market growth is favored by a CAGR of 7.3% during the forecast period 2019 to 2025.
The statistic indicates that the global biobanking market is projected to experience a Compound Annual Growth Rate (CAGR) of 7.3% from 2019 to 2025. This implies that the market for biobanking services and infrastructure is expected to expand steadily over the forecast period. A CAGR of 7.3% suggests a moderate but consistent growth rate, reflecting increasing demand for biobanking solutions, advancements in biobanking technologies, and rising investments in research and development activities within the healthcare and life sciences industries. Overall, this statistic signifies positive prospects for the biobanking market in the coming years.
Biobanking for medical research revenue in the U.S. in 2023 is expected to be around USD 61 million.
The statistic stating that biobanking for medical research revenue in the U.S. is expected to reach around USD 61 million in 2023 indicates the projected total amount of revenue generated from biobanking services specifically tailored for medical research purposes within the United States for that year. This figure represents the anticipated financial value derived from the storage and management of biological samples such as tissues, blood, and other biospecimens that are collected, processed, and preserved for scientific investigation and analysis. Biobanking plays a crucial role in advancing medical research by providing researchers with access to a wide range of biological materials for studying diseases, developing treatments, and conducting various biomedical studies. The projected revenue of USD 61 million reflects the growing importance and demand for biobanking services among researchers and organizations in the healthcare and life sciences sectors, highlighting the significant economic impact and value of biobanking activities in supporting scientific advancements and healthcare innovation.
As of 2015, the Norwegian Mother and Child Cohort Study stored over 400,000 samples.
The statistic indicates that as of 2015, the Norwegian Mother and Child Cohort Study (MoBa) has collected and stored over 400,000 samples from participants. This study is a large prospective pregnancy cohort study that aims to investigate the effects of lifestyle, genetic factors, and environmental exposures on maternal and child health outcomes. The substantial number of stored samples signifies the extensive scale and potential of the study to analyze various research questions related to pregnancy, child development, and health. Having such a vast repository of biological samples allows researchers to conduct diverse analyses and explore complex relationships between exposures and outcomes, contributing valuable insights to the field of maternal and child health.
Over 120 projects have been performed based on the Swedish Twin Registry biobank until 2020.
The statistic indicates that up until the year 2020, there have been over 120 projects conducted using data or samples from the Swedish Twin Registry biobank. This implies that researchers and scientists have utilized the valuable resources available in the biobank to investigate a wide range of research questions related to genetics, health, and various other scientific disciplines. The substantial number of projects highlights the significance of the Swedish Twin Registry biobank as a crucial repository for researchers looking to study the impact of genetics on various aspects of health and disease.
There were 512 biobanks in China by the end of 2017.
The statistic “There were 512 biobanks in China by the end of 2017” indicates the total number of biobanks established in China by the specified year. Biobanks are repositories that store biological samples such as tissues, blood, and DNA for research purposes. The presence of a large number of biobanks reflects the growing importance and interest in biomedical research and personalized medicine in China. These biobanks play a crucial role in facilitating medical research, drug development, and precision healthcare by providing researchers with access to a wide range of biological materials for analysis and study. The proliferation of biobanks in China also signifies the nation’s commitment to advancing scientific research and innovation in the field of biomedicine.
The U.K. Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the country.
The statistic indicates that the U.K. Biobank, a large-scale biomedical research project, enrolled 500,000 individuals aged between 40 and 69 years old during the period of 2006 to 2010. This diverse group of participants was recruited from various regions across the United Kingdom, providing a representative sample of the adult population within this age range. The collection of data and biological samples from this extensive cohort allows researchers to conduct comprehensive studies on a wide range of health-related issues, including genetics, lifestyle factors, and the development of chronic diseases. The substantial size and demographic diversity of the U.K. Biobank cohort enable scientists to explore complex relationships between genetic predispositions, environmental influences, and health outcomes, ultimately contributing to advancements in the understanding and treatment of various health conditions.
The U.K. Biobank has 15 million samples to be used by approved scientists from the U.K. and overseas.
The statistic that the U.K. Biobank has 15 million samples available for use by approved scientists from the U.K. and overseas indicates a vast and valuable resource for research in various fields such as genetics, epidemiology, and medical sciences. These samples likely include biological specimens like blood, urine, and tissue, as well as accompanying data on participants’ health, lifestyle, and genetic information. The size and diversity of the Biobank make it a significant asset for researchers looking to study a wide range of health conditions, genetic factors, and environmental influences on human health. By allowing approved scientists from different parts of the world to access these samples, the U.K. Biobank facilitates collaborative and cutting-edge research that can potentially lead to important discoveries and advancements in healthcare.
Conclusion
The statistics presented in this post shed light on the significant growth and impact of the biobanking industry. With increasing demand for high-quality biospecimens for research and medical advancements, biobanking continues to play a crucial role in advancing scientific discoveries. As technology and innovation continue to drive the growth of this industry, it is poised for further expansion and development in the coming years.
References
0. – https://www.www.reportocean.com
1. – https://www.pubmed.ncbi.nlm.nih.gov
2. – https://www.www.biobanksverige.se
3. – https://www.www.statista.com
4. – https://www.www.ukbiobank.ac.uk
5. – https://www.www.ncbi.nlm.nih.gov
6. – https://www.www.frontiersin.org
7. – https://www.www.globenewswire.com
8. – https://www.www.borgenmagazine.com
9. – https://www.www.grandviewresearch.com
10. – https://www.ki.se
